MSB 2.17% $1.13 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-189

  1. 571 Posts.
    lightbulb Created with Sketch. 160
    The submitter of the comment is from NSW, Australia, so I find it highly unlikely to be the same person.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.